Westside Current on MSN23 小时
TEPEZZA® (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ACTIVE THYROID EYE ...
Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the ...
They sting. They bite. They can (maybe) kill you. These are Arizona's scariest bugs
These 10 common Arizona insects, arachnids and reptiles deliver painful bites. Here's how dangerous each one is and when to ...
Washington Monthly8 小时
The Chaos of the Supreme Court’s Last Term—and What May Be Coming This Time
The Chaos of the Supreme Court’s Last Term—and What May Be Coming This Time. With their new term starting October 7, the nine ...
The New York Times19 小时
Live Updates: U.S. Works to Broker Cease-Fire Between Israel and Hezbollah
Karamallah Daher/Reuters The United States is working to broker a short-term cease-fire to halt the spasm of violence between Israel and Hezbollah in the hopes ... will show them what it means to face ...
Quiz that'll put an end to headache misery: Top doctors reveal every kind, how to diagnose ...
A dull ache, a stabbing pain round the eyes, or one-sided throbbing - headaches can take a variety of forms but they affect ...
Amgen: Tepezza (teprotumumab) Receives Approval In Japan For The Treatment Of Active ...
Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the treatment of active or high ...